Diagnostics

Embleema Awarded $5M Department of Defense Contract. Partners With GRAVL and Aria Diagnostics to Create Global Pathogen Bio Surveillance Infrastructure

BOSTON, Sept. 29, 2025 /PRNewswire/ -- Embleema, in partnership with GRAVL and Aria Diagnostics (ARIA), has secured a $5 million...

Medical Drones Market Set for 22.19% CAGR from 2025 to 2030, Driven by Expanding Healthcare Delivery Solutions, Says Mordor Intelligence

HYDERABAD, India, Sept. 26, 2025 /PRNewswire/ -- According to a recent report by Mordor Intelligence, the medical drones market size...

OPEN Healthcare Celebrates Grand Opening of 23,000 Sq. Ft. Innovative Diagnostic Laboratory and Launch of At-Home Testing Service in Gardena, California

GARDENA, CALIFORNIA / ACCESS Newswire / September 25, 2025 / OPEN Healthcare proudly announces the grand opening of its new...

Digital Pathology Market to Surpass US$ 3.86 Billion by 2033 as AI-Enabled Diagnostics and Telepathology Redefine Global Healthcare | DataM Intelligence

AUSTIN, Texas and TOKYO, Sept. 25, 2025 /PRNewswire/ -- The Digital Pathology Market Size reached US$ 1.31 Billion in 2024...

New ixlayer Survey Finds 73% of Pharma Leaders Are Running or Planning to Launch a DTP Program in the Next Year, and Half Say DTP Will Be Standard Practice Within Five Years

82% say fragmented care continues to undermine DTC advertising effectiveness, signaling the need for a new strategy SAN FRANCISCO, Sept....

Plus Therapeutics Announces National Coverage Agreement with UnitedHealthcare Insurance Company for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer

HOUSTON, Sept. 25, 2025 (GLOBE NEWSWIRE) -- CNSide Diagnostics, LLC, a wholly-owned subsidiary of Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”),...

Algernon Announces CAD $4 Million Non-Dilutive Financing to Open Four Brain-Specific PET Scan Clinics in the U.S. for Early Stage Alzheimer’s Detection

VANCOUVER, British Columbia, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB:...

RetinalGenix Technologies Advances Home and Remote Monitoring Patent Portfolio, Positioning for the Future of Ocular and Systemic Disease Care

APOLLO BEACH, Fla., Sept. 25, 2025 (GLOBE NEWSWIRE) -- RetinalGenix Technologies Inc. (OTCQB:RTGN) (“RetinalGenix” or the “Company”), a pioneering developmental-stage...

Cognision and SOMNOmedics Forge Strategic Partnership to Advance Sleep Biomarkers in Pharmaceutical Clinical Trials

LOUISVILLE, Ky., Sept. 24, 2025 /PRNewswire/ -- Cognision, a leader in high-performance neurophysiological biomarker solutions and services, has announced a...

Mobile Gamma Cameras Market Surges to USD 800 Million by 2033, Propelled by 7.3% CAGR – Verified Market Reports®

The Mobile Gamma Cameras Market is experiencing strong momentum driven by rising demand for point-of-care diagnostic imaging, advancements in nuclear...

error: Content is protected !!